Ausgabe 3/2024
Inhalt (28 Artikel)
Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections
- Guidelines
Tao Chen, Guang Chen, Guiqiang Wang, Sombat Treeprasertsuk, Cosmas Rinaldi Adithya Lesmana, Han-Chieh Lin, Mamun Al-mahtab, Yogesh K. Chawla, Soek-Siam Tan, Jia-Horng Kao, Man-Fung Yuen, Guan-Huei Lee, Diana Alcantara-Payawal, Nobuaki Nakayama, Zaigham Abbas, Wasim Jafri, Dong-Joon Kim, Ashok Choudhury, Rakhi Mahiwall, Jinlin Hou, Saeed Hamid, Jidong Jia, J. S. Bajaj, Fusheng Wang, Shiv K. Sarin, Qin Ning
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure
- Guidelines
Rakhi Maiwall, Satender Pal Singh, Paolo Angeli, Richard Moreau, Aleksander Krag, Virender Singh, Ashwani K. Singal, S. S. Tan, Puneet Puri, Mamun Mahtab, George Lau, Qin Ning, Manoj Kumar Sharma, P. N. Rao, Dharmesh Kapoor, Subhash Gupta, Ajay Duseja, Manav Wadhawan, Dinesh Jothimani, Sanjiv Saigal, Sunil Taneja, Akash Shukla, Pankaj Puri, Deepak Govil, Gaurav Pandey, Kaushal Madan, C. E. Eapen, Jaya Benjamin, Ashok Chowdhury, Shweta Singh, Vaishali Salao, Jin Mo Yang, Saeed Hamid, Shalimar, Sanjiv Jasuja, Anand V. Kulkarni, Madund A. Niriella, Harsh Vardhan Tevethia, Vinod Arora, R. P. Mathur, Akash Roy, Ankur Jindal, Neeraj Saraf, Nipun Verma, Arka De, Narendra S. Choudhary, Rohit Mehtani, Phool Chand, Omkar Rudra, Shiv Kumar Sarin
Are dairy products the answer to metabolic dysfunction-associated fatty liver disease?
- Editorial
Kristopher Cho-Hei Lau, Vincent Wai-Sun Wong
Gut-microbiome composition and function in progression of alcohol-associated liver disease: going beyond western experiences
- Editorial
Gowthami Kanagalingam, Jasmohan S. Bajaj
Surgical risk stratification in patients with cirrhosis
- Review Article
Ana Ostojic, Nadim Mahmud, K. Rajender Reddy
Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis
- Open Access
- Original Article
Shaowen Jiang, Simin Guo, Yan Huang, Yalin Yin, Jingwen Feng, Huijuan Zhou, Qing Guo, Weijing Wang, Haiguang Xin, Qing Xie
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments
- Original Article
Shuyan Chen, Jialing Zhou, Xiaoning Wu, Tongtong Meng, Bingqiong Wang, Hui Liu, Tailing Wang, Xinyan Zhao, Xinyu Zhao, Yuanyuan Kong, Xiaojuan Ou, Jidong Jia, Yameng Sun, Hong You
Global burden and trends of acute viral hepatitis among children and adolescents from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019
- Original Article
Wanglong Xiao, Jingwei Zhao, Yiwen Chen, Xingzhu Liu, Chang Xu, Jiaxu Zhang, Yongbing Qian, Qiang Xia
FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence
- Open Access
- Original Article
Benedikt Simbrunner, Benedikt S. Hofer, Philipp Schwabl, Kerstin Zinober, Oleksandr Petrenko, Claudia Fuchs, Georg Semmler, Rodrig Marculescu, Mattias Mandorfer, Christian Datz, Michael Trauner, Thomas Reiberger
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease
- Original Article
Shao-Wen Wang, Tsung-Han Hsieh, Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes
- Original Article
Xiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, Zhiwen Fan, Xiaoming Xu, Fajuan Rui, Wenjing Ni, Qi Gu, Xin Tong, Shengxia Yin, Xiaolong Qi, Junping Shi, Chao Wu, Jie Li
MAFLD identifies patients with significant hepatic fibrosis better than MASLD
- Original Article
Ziyan Pan, Said A. Al-Busafi, Maheeba Abdulla, Yasser Fouad, Giada Sebastiani, Mohammed Eslam
Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma
- Original Article
Hyung-Don Kim, Young-Gyu Park, Sejin Kim, Kyu-Pyo Kim, Sook-Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, Changhoon Yoo
Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1–AXL signal relay in liver cancer cells
- Original Article
Toshimitsu Tanaka, Hironori Koga, Hiroyuki Suzuki, Hideki Iwamoto, Takahiko Sakaue, Atsutaka Masuda, Toru Nakamura, Jun Akiba, Hirohisa Yano, Takuji Torimura, Takumi Kawaguchi
Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies
- Original Article
Wen Chen, Xiaodan Lin, Zhenheng Wu, Wei Pan, Qiming Ke, Yanling Chen
Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH)
- Open Access
- Original Article
Melek Büyük, Neslihan Berker, Doğu Vurallı Bakkaloğlu, İbrahim Volkan Şenkal, Zerrin Önal, Mine Güllüoğlu
Validation of Baveno VII criteria for clinically significant portal hypertension by two-dimensional shear wave elastography
- Original Article
Ruiling He, Chuan Liu, Ivica Grgurevic, Ying Guo, Huixiong Xu, Jiacheng Liu, Yunfang Liu, XiaoYan Wang, Hongmei Shi, Anita Madir, Kristian Podrug, Yuli Zhu, Yongli Hua, Kun Wang, Jing Wen, Meiqin Su, Qun Zhang, Jie Li, Xiaolong Qi
Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases
- Original Article
Ming Liu, Quan Bao, Tingting Zhao, Longfei Huang, Danhua Zhang, Yanyan Wang, Xiaoluan Yan, Hongwei Wang, Kemin Jin, Wei Liu, Kun Wang, Baocai Xing
Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation
- Open Access
- Original Article
Shu Feng, Xingming Xie, Jianchao Li, Xu Xu, Chaochun Chen, Gaoliang Zou, Guoyuan Lin, Tao Huang, Ruihan Hu, Tao Ran, Lu Han, Qingxiu Zhang, Yuanqingxiao Li, Xueke Zhao
Impact of chronic hepatitis B and concurrent steatosis on the risk of hepatocellular carcinoma
- Letter to the Editor
Ibrahim Ayada, Jiajing Li, Willem Pieter Brouwer, Robert J. de Knegt, Qiuwei Pan
“Dosis sola facit venenum”—Evidence for causality in the association between ketamine and cholestatic liver injury
- Open Access
- Letter to the Editor
Pedro David Wendel-Garcia, Rea Andermatt, Christian Bode, Sascha David, Klaus Stahl
Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed
- Letter to the Editor
Shiye Yang, Huoqi Liang, Xing Li, Jiayi Qian, Zhibing Ming
The safety profile of endoscopic variceal ligation in patients with esophageal varices
- Letter to the Editor
Jake E. Krige, Eduard G. Jonas, Marc M. Bernon
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
- Correction
Jitao Wang, Qiran Zhang, Jingwen Ai, Dengxiang Liu, Chuan Liu, Huiling Xiang, Ye Gu, Ying Guo, Jiaojian Lv, Yifei Huang, Yanna Liu, Dan Xu, Shubo Chen, Jinlong Li, Qianqian Li, Jing Liang, Li Bian, Zhen Zhang, Xiaoqing Guo, Yinong Feng, Luxiang Liu, Xuying Zhang, Yanliang Zhang, Faren Xie, Shujun Jiang, Wei Qin, Xiaodong Wang, Wei Rao, Qun Zhang, Qiuju Tian, Ying Zhu, Qingwei Cong, Juan Xu, Zhiyun Hou, Nina Zhang, Aiguo Zhang, Hongmei Zu, Yun Wang, Zhaolan Yan, Xiufang Du, Aifang Hou, Yan Yan, Yuanwang Qiu, Hangyuan Wu, Shengjuan Hu, Yanhong Deng, Jiansong Ji, Jie Yang, Jiansheng Huang, Zhongwei Zhao, Shengqiang Zou, Hailei Ji, Guohong Ge, Li Zhong, Song He, Xiaosong Yan, Bian Ba Yangzhen, Ci Qu, Liting Zhang, Shiying Yang, Xiaoqin Gao, Muhan Lv, Qingliang Zhu, Xinxin Xu, Qing-Lei Zeng, Xiaolong Qi, Wenhong Zhang
Correction to: Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma
- Correction
Ying Xu, Guangchao Luan, Feng Liu, Yuhua Zhang, Zhongchao Li, Ziming Liu, Tao Yang
Correction to: Targeting ferroptosis in hepatocellular carcinoma
- Correction
Yuqian Mo, Zhilin Zou, Erbao Chen
Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines
- Correction
Wei Teng, Ting‑Tsung Chang, Hwai‑I Yang, Cheng‑Yuan Peng, Chien‑Wei Su, Tung‑Hung Su, Tsung‑Hui Hu, Ming‑Lung Yu, Hung‑Chih Yang, Jaw‑Ching Wu
Correction to: Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease
- Correction
Itsuo Nagayama, Kenya Kamimura, Takashi Owaki, Masayoshi Ko, Takuro Nagoya, Yuto Tanaka, Marina Ohkoshi, Toru Setsu, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Shuji Terai
